Skip to Content

Dr. Patricia Buehler receives People’s Choice Award for innovative new eyelid surgery device

 Dr. Patricia Buehler, CEO of Osheru, has won the Eyecelerator People's Choice Award for her groundbreaking Ziplyft device, a minimally invasive solution for eyelid surgery!
Dr. Patricia Buehler, CEO of Osheru, has won the Eyecelerator People's Choice Award for her groundbreaking Ziplyft device, a minimally invasive solution for eyelid surgery!

BEND, Ore. (KTVZ) -- Patricia Buehler, MD, MPH, an eye surgeon from Bend, and founder and CEO of Osheru, won the Eyecelerator People’s Choice Award for her innovative new device for blepharoplasty, or eyelid surgery, the Ziplyft.

The Ziplyft has secured consecutive prestigious awards from Eyecelerator, a leading ophthalmology innovation catalyst.

At Eyecelerator's annual innovator sessions, preceding the American Cataract and Refractive Surgery (ASCRS) Meeting, on April 5th in Boston, MA, Dr. Buehler's Ziplyft won the coveted People's Choice Award, as selected by attendees. This recognition celebrates an outstanding cutting-edge startup in the ophthalmic space, and it follows Ziplyft's triumph last year when it won the Winning Pitch Award.

Upper eyelid surgery, or blepharoplasty, is consistently among the top five most popular cosmetic surgical procedures performed in the United States1, underscoring the significant demand and market potential for innovative solutions in this field.

Traditional blepharoplasty techniques have remained largely unchanged for over 50 years, often requiring invasive surgical methods, extensive recovery times, and posing risks of post-operative complications like bruising, asymmetry, and suture issues.

Leveraging her 25+ years’ surgical experience as an Ophthalmologist, Dr. Buehler developed and patented Ziplyft, a minimally invasive alternative to the traditional blepharoplasty technique. The Ziplyft is designed to offer reduced downtime, post-operative bruising, and the need for sutures, while providing symmetric results.

“As a woman who’s had eyelid surgery and a surgeon who has performed thousands of eyelid surgeries, I was in a unique position to recognize the pain points for surgeons and for my patients with the traditional blepharoplasty technique,” says Dr. Buehler.

Launching in early 2025, Ziplyft is poised to revolutionize the procedure, providing a long-awaited solution to the limitations of conventional blepharoplasty techniques.

Dr. Buehler’s achievement is unprecedented, winning back-to-back Eyecelerator awards and further underscores its ingenuity, potential to transform upper eyelid surgery, and remarkable progress of Osheru and the Ziplyft.

About Osheru and Ziplyft:

Osheru is an innovative medical device company revolutionizing eyelid surgery procedures. The company's pioneering Ziplyft product facilitates minimally invasive blepharoplasty (eyelid surgery) for ophthalmologists, oculoplastic surgeons, and facial plastic surgeons. Slated for commercialization in early 2025, the Ziplyft's proprietary design introduces a novel surgical

approach to removing excess eyelid skin through an advanced outpatient procedure. This specialized device is designed to enhance the surgical process and reduced recovery time compared to traditional methods. Learn more at:

About Eyecelerator:

Eyecelerator advances eye care innovation by connecting entrepreneurs, investors, physicians, and business leaders through next-generation conferences. The company provides seed investments, mentorship, and strategic connections to transform novel ophthalmic concepts into successful businesses. Learn more at

1American Society of Plastic Surgeons, 2020 Plastic Surgery Statistics Report

Article Topic Follows: Community Billboard

Jump to comments ↓

KTVZ news sources


KTVZ NewsChannel 21 is committed to providing a forum for civil and constructive conversation.

Please keep your comments respectful and relevant. You can review our Community Guidelines by clicking here

If you would like to share a story idea, please submit it here.

Skip to content